Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Health Impact Study of Aquatabs in Tamale, Ghana
This study has been completed.
Sponsors and Collaborators: Centers for Disease Control and Prevention
Medentech Ltd.
Emory University Center for Global Safe Water
NewEnergy
University for Development Studies, Tamale, Ghana
Information provided by: Centers for Disease Control and Prevention
ClinicalTrials.gov Identifier: NCT00252928
  Purpose

The purpose of this study to determine whether Aquatabs, a water treatment tablet, reduces diarrheal diseases in a peri-urban population of Tamale, Ghana.


Condition Intervention
Diarrhea
Other: Sodium dichloroisocyanurate (NaDCC) tablets
Other: Placebo

MedlinePlus related topics: Diarrhea Dietary Sodium Drinking Water
Drug Information available for: Sodium dichloroisocyanurate Dichloroisocyanuric acid
U.S. FDA Resources
Study Type: Interventional
Study Design: Prevention, Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Factorial Assignment, Efficacy Study
Official Title: Health Impact Study of a Water Treatment Tablet, Aquatabs, in Tamale, Ghana

Further study details as provided by Centers for Disease Control and Prevention:

Primary Outcome Measures:
  • Measure the impact of Aquatabs on diarrhea among persons in households in Tamale, Ghana. [ Time Frame: 12 weeks ]

Secondary Outcome Measures:
  • Assess the microbiological quality of household water among persons living in Tamale, Ghana. [ Time Frame: 12 weeks ]
  • Determine the acceptability of Aquatabs. [ Time Frame: 12 weeks ]

Enrollment: 240
Study Start Date: July 2006
Study Completion Date: November 2006
Arms Assigned Interventions
A: Placebo Comparator
Placebo group does not receive Aquatabs.
Other: Placebo
Placebo
B: Experimental
Intervention arms receives Aquatabs.
Other: Sodium dichloroisocyanurate (NaDCC) tablets
Intervention arm receives NaDCC tablets to use for to disinfect their household water for use for 20L of water. Ideally, disinfection occurs every day.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Households with at least one child under 5 years old

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00252928

Locations
United States, Georgia
Emory University Center for Global Safe Water
Atlanta, Georgia, United States, 30322
Ghana
NewEnergy
Tamale, Ghana
University of Development Studies
Tamale, Ghana
Sponsors and Collaborators
Medentech Ltd.
Emory University Center for Global Safe Water
NewEnergy
University for Development Studies, Tamale, Ghana
Investigators
Principal Investigator: Seema Jain, MD Centers for Disease Control and Prevention
Principal Investigator: Robert Quick, MD Centers for Disease Control and Prevention
  More Information

World Health Organization: Global Water Supply and Sanitation Assessment 2000 Report  This link exits the ClinicalTrials.gov site
Centers for Disease Control and Prevention: Safe Water System  This link exits the ClinicalTrials.gov site
United States Environmental Protection Agency: Product Label for Occidental Chemical Corporation Sodium Dichloroisocyanurate.  This link exits the ClinicalTrials.gov site

Publications:
Study ID Numbers: CDC-NCID-4730
Study First Received: November 10, 2005
Last Updated: October 29, 2007
ClinicalTrials.gov Identifier: NCT00252928  
Health Authority: United States: Federal Government;   Ghana: University for Development Studies

Keywords provided by Centers for Disease Control and Prevention:
sodium dichloroisocyanurate
water purification
disinfection
Ghana

Study placed in the following topic categories:
Diarrhea
Troclosene
Clotrimazole
Miconazole
Tioconazole

Additional relevant MeSH terms:
Anti-Infective Agents
Disinfectants
Therapeutic Uses
Antifungal Agents
Antiviral Agents
Pharmacologic Actions

ClinicalTrials.gov processed this record on January 14, 2009